INTRODUCTION AND OBJECTIVES: Information in primary care databases can be useful in research, but the validity of these data needs to be evaluated. We sought to analyze the validity of the data used in the EMMA study based on data from the Information System for the Development of Research in Primary Care. METHODS: We compared the prevalence of cardiovascular risk factors observed in EMMA-hypertension, diabetes, hypercholesterolemia (and its treatments), obesity, and smoking-with equivalent data from the Registre Gironí del Cor (REGICOR), a population-based study that uses standardized methodology, in 2000. We also compared the incidence rates of vascular diseases and its association with these risk factors in a 5-year follow-up. RESULTS: We analyzed data from 34 823 participants included in EMMA and 2540 REGICOR2000 study participants aged 35 to 74. The prevalence of risk factors did not differ significantly between the 2 studies, except for the prevalence of former smokers in men, which was higher in REGICOR2000 (24.7% [95% confidence interval, 23.9%-25.5%] vs 30.1% [95% confidence interval, 27.1%-33.1%]), and the proportion of patients with lipid-lowering and antihypertensive therapy, which was higher in EMMA (46.9% vs 32.7% and 8.7% vs 6.3%, respectively). There were no differences between the 2 studies when comparing the incidence of vascular diseases (2.1% in both studies in men and 1.18% [95% confidence interval, 0.7%-1.7%] in REGICOR2000 vs 0.75% [95% confidence interval, 0.64%-0.87%] in EMMA in women) and its association with risk factors. CONCLUSIONS: The prevalence of cardiovascular risk factors and their association with the incidence of vascular disease observed in the EMMA study are consistent with those observed in an epidemiological population-based study with a standardized methodology.
INTRODUCTION AND OBJECTIVES: Information in primary care databases can be useful in research, but the validity of these data needs to be evaluated. We sought to analyze the validity of the data used in the EMMA study based on data from the Information System for the Development of Research in Primary Care. METHODS: We compared the prevalence of cardiovascular risk factors observed in EMMA-hypertension, diabetes, hypercholesterolemia (and its treatments), obesity, and smoking-with equivalent data from the Registre Gironí del Cor (REGICOR), a population-based study that uses standardized methodology, in 2000. We also compared the incidence rates of vascular diseases and its association with these risk factors in a 5-year follow-up. RESULTS: We analyzed data from 34 823 participants included in EMMA and 2540 REGICOR2000 study participants aged 35 to 74. The prevalence of risk factors did not differ significantly between the 2 studies, except for the prevalence of former smokers in men, which was higher in REGICOR2000 (24.7% [95% confidence interval, 23.9%-25.5%] vs 30.1% [95% confidence interval, 27.1%-33.1%]), and the proportion of patients with lipid-lowering and antihypertensive therapy, which was higher in EMMA (46.9% vs 32.7% and 8.7% vs 6.3%, respectively). There were no differences between the 2 studies when comparing the incidence of vascular diseases (2.1% in both studies in men and 1.18% [95% confidence interval, 0.7%-1.7%] in REGICOR2000 vs 0.75% [95% confidence interval, 0.64%-0.87%] in EMMA in women) and its association with risk factors. CONCLUSIONS: The prevalence of cardiovascular risk factors and their association with the incidence of vascular disease observed in the EMMA study are consistent with those observed in an epidemiological population-based study with a standardized methodology.
Authors: D Prieto-Alhambra; F F Avilés; A Judge; T Van Staa; X Nogués; N K Arden; A Díez-Pérez; C Cooper; M K Javaid Journal: Osteoporos Int Date: 2012-02-04 Impact factor: 4.507
Authors: K Berencsi; A Sami; M S Ali; K Marinier; N Deltour; S Perez-Gutthann; L Pedersen; P Rijnbeek; J Van der Lei; F Lapi; M Simonetti; C Reyes; M C J M Sturkenboom; D Prieto-Alhambra Journal: Osteoporos Int Date: 2019-11-06 Impact factor: 4.507
Authors: Marc Casajuana; Maria Giner-Soriano; Albert Roso-Llorach; Cristina Vedia; Concepció Violan; Rosa Morros Journal: Eur J Health Econ Date: 2018-02-20
Authors: Gemma Ibáñez-Sanz; Elisabet Guinó; Caridad Pontes; Rosa Morros; Luisa C de la Peña-Negro; Mª Ángeles Quijada-Manuitt; Victor Moreno Journal: Eur J Epidemiol Date: 2019-11-16 Impact factor: 8.082
Authors: C Reyes; P Estrada; X Nogués; P Orozco; C Cooper; A Díez-Pérez; F Formiga; J González-Macías; J G Mácias; D Prieto-Alhambra Journal: Osteoporos Int Date: 2014-03-28 Impact factor: 4.507
Authors: Maria Del Mar Vila; Beatriz Remeseiro; Laura Igual; Roberto Elosua; Rafel Ramos; Jose Manuel Valdivielso; Ruth Martí-Lluch; Jaume Marrugat; Maria Grau Journal: Hypertens Res Date: 2021-04-08 Impact factor: 3.872
Authors: Marti Catala; Ermengol Coma; Sergio Alonso; Enrique Álvarez-Lacalle; Silvia Cordomi; Daniel López; Francesc Fina; Manuel Medina-Peralta; Clara Prats; Daniel Prieto-Alhambra Journal: Front Public Health Date: 2021-07-05